home / stock / cing / cing news

CING News and Press, Cingulate Inc. From 02/06/24

Stock Information
Company Name: Cingulate Inc.
Stock Symbol: CING
Market: NASDAQ
Website: cingulate.com
Menu
CING CING Quote CING Short CING News CING Articles CING Message Board
Get CING Alerts

News, Short Squeeze, Breakout and More Instantly...
CING - Cingulate Announces Closing of $7.5 Million Public Offering

KANSAS CITY, Kan., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR&#x...
CING - US Companies Moving the Markets, Morning edition
Mon, Feb 05, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 5.0% to $11.72 on volume of 189,765,259 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.8% to $5.09 on volume of 143,664,257 shares Amazon.com Inc. (AMZN) rose 7.9% to $171.81 on volume of ...

CING - US Companies Moving the Markets, Evening edition
Fri, Feb 02, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) fell 5.5% to $11.665 on volume of 166,461,596 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 4.1% to $5.075 on volume of 129,958,072 shares Remark Holdings Inc. (MARK) rose 16.2% to $0.593899 on ...

CING - KOPN, CAMP and FGEN among mid-day movers

2024-02-02 12:31:34 ET More on Mid-day movers & stocks. CalAmp Corp. (CAMP) Q3 2024 Earnings Call Transcript Kopin: Visionary Leadership Fuels Growth And Market Potential Kopin Corporation (KOPN) Q3 2023 Earnings Call Transcript CalAmp GAAP EPS of -$2.27 ...
CING - Cingulate stock sinks after it prices its public offering to raise $7.5M

2024-02-02 09:26:43 ET More on Cingulate New ADHD drugs could pay off for pharmaceutical companies Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alpha’s Quant Rating on Cingulate Read the full article on Seeking Alpha For fu...

CING - Cingulate Announces Pricing of $7.5 Million Public Offering

KANSAS CITY, Kan., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (“Cingulate,” the “Company,” “we,” “our” or “us”), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR&#x...

CING - BFRI and CING among pre-market losers

2024-02-02 08:21:14 ET More on pre-market losers & stocks etc. Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript New ADHD drugs could pay off for pharmaceutical companies Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alphaȁ...
CING - Cingulate promotes Jennifer Callahan to CFO

2024-01-29 08:24:01 ET More on Cingulate New ADHD drugs could pay off for pharmaceutical companies Laidlaw cuts Cingulate to hold, cites dwindling resources Seeking Alpha’s Quant Rating on Cingulate Historical earnings data for Cingulate Financ...

CING - Longtime Cingulate Controller Jennifer Callahan Promoted to CFO

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical ...

CING - Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical p...
Previous 10 Next 10